Skip to main content
Equibles

Monaco Asset Management SAM

Position in PRQR — ProQR Therapeutics N.V.

CIK 1803593 Monaco, O9
Back to PRQR Full portfolio

Position in PRQR

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$454,745
-$223,715 QoQ
Shares Held
244,487
-41.6% QoQ
Ownership
0.173%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#28
of 69 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PRQR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Monaco Asset Management SAM holds $49,930,003 across 9 Biotechnology names. PRQR ranks #9 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MRVI
Maravai Lifesciences Holdings, Inc.
 2,231,026 $13,921,602
2 BMRN
Biomarin Pharmaceutical Inc
 184,937 $10,582,095
3 RCKT
Rocket Pharmaceuticals, Inc.
 2,480,468 $8,483,200
4 NKTX
Nkarta, Inc.
 2,373,400 $6,716,722
5 NVAX
Novavax Inc
 577,464 $5,439,710
6 PLRX
Pliant Therapeutics, Inc.
 1,938,747 $2,210,171
7 VNDA
Vanda Pharmaceuticals Inc.
 221,286 $1,354,270
8 LKFT
Lakefront Biotherapeutics NV
 25,600 $767,488

All Filings in PRQR

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $454,745 244,487
2026-03-31 $678,460 418,803
2025-12-31 $866,182 428,803
2025-09-30 $979,800 460,000
2025-06-30 $938,400 460,000
2025-03-31 $627,637 471,908
2024-12-31 $786,037 296,618
2024-09-30 $596,763 327,892
2024-06-30 $518,964 312,629
2024-03-31 $715,920 312,629
2023-12-31 $749,382 378,476
2023-09-30 $490,772 377,517
2023-06-30 $384,777 237,517
2023-03-31 $381,981 179,334
2022-12-31 $610,500 165,000
2022-09-30 $692,961 931,400
2022-06-30 $724,629 931,400
2022-03-31 $82,264 90,900